long-acting GLP-1RAs on AMD, long-acting agents are known to be more effective in terms of glycemic control and body weight, and it has been suggested that weight-loss mediated pathways may drive the ocular benefits associated with GLP-1RA use. However, they pointed out that this study cohort was matched for hemoglobin A1c and BMI, which decreases the likelihood that the more pronounced benefit associated with long-term agents is due to these factors alone. Moreover, in obese and non-obese individuals, GLP-1 agonist therapy exhibited comparable reduced risks of dry (21% vs
Our team designs every plan individually, and we never recommend more than what is safe and appropriate for your specific situation
Bc 3: sn phm kh t nhin trc khi mc o
This approach should only be considered under direct medical supervision, never as self-directed modification
Additionally, clinical trials have shown that GLP-1RAs improve liver histology in patients with MASLD and NASH, as evidenced by reductions in liver fat and inflammation (Gu et al., 2023)
Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age
